Ping Tang

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. ncbi Predictors of nipple-areolar complex involvement by breast carcinoma: histopathologic analysis of 787 consecutive therapeutic mastectomy specimens
    Jianli Wang
    Department of Pathophysiology, Shandong University School of Medicine, Shandong, China
    Ann Surg Oncol 19:1174-80. 2012
  2. ncbi Molecular classifications of breast carcinoma with similar terminology and different definitions: are they the same?
    Ping Tang
    University of Rochester Medical Center, Department of Pathology, Box 626, Rochester, NY 14642, USA
    Hum Pathol 39:506-13. 2008
  3. ncbi Relationship between nuclear grade of ductal carcinoma in situ and cell origin markers
    Ping Tang
    Department of Pathology and Laboratory Medicine, University of Rochester Medical Center Box 626, 601 Elmwood Ave, Rochester, NY 14642, USA
    Ann Clin Lab Sci 36:16-22. 2006
  4. ncbi Expression patterns of ER-alpha, PR, HER-2/neu, and EGFR in different cell origin subtypes of high grade and non-high grade ductal carcinoma in situ
    Ping Tang
    Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, 601 Elmwood Ave, Box 626, Rochester, New York 14642 USA
    Ann Clin Lab Sci 36:137-43. 2006
  5. ncbi Ductal carcinoma in situ: a review of recent advances
    Ping Tang
    Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York 14642, USA
    Curr Opin Obstet Gynecol 19:63-7. 2007
  6. ncbi Molecular classification of breast carcinomas by immunohistochemical analysis: are we ready?
    Ping Tang
    Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA
    Diagn Mol Pathol 18:125-32. 2009
  7. ncbi A lower Allred score for progesterone receptor is strongly associated with a higher recurrence score of 21-gene assay in breast cancer
    Ping Tang
    Department of Pathology, University of Rochester of Rochester Medical Center, New York, USA
    Cancer Invest 28:978-82. 2010
  8. ncbi Reduced expression of tocopherol-associated protein (TAP/Sec14L2) in human breast cancer
    Xi Wang
    Department of Pathology and Laboratory Medicine, University of Rochester Medical School, Rochester, New York, USA
    Cancer Invest 27:971-7. 2009
  9. ncbi Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast
    Krisztina Hanley
    Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA
    Hum Pathol 39:386-92. 2008
  10. ncbi Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast
    Sharon Steinman
    Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York 14642, USA
    Ann Clin Lab Sci 37:127-34. 2007

Collaborators

Detail Information

Publications17

  1. ncbi Predictors of nipple-areolar complex involvement by breast carcinoma: histopathologic analysis of 787 consecutive therapeutic mastectomy specimens
    Jianli Wang
    Department of Pathophysiology, Shandong University School of Medicine, Shandong, China
    Ann Surg Oncol 19:1174-80. 2012
    ..We sought to identify the predictive factors for NAC involvement in breast cancer patients...
  2. ncbi Molecular classifications of breast carcinoma with similar terminology and different definitions: are they the same?
    Ping Tang
    University of Rochester Medical Center, Department of Pathology, Box 626, Rochester, NY 14642, USA
    Hum Pathol 39:506-13. 2008
    ..More studies are needed to evaluate to their values in predicting prognosis and guiding individualized therapy...
  3. ncbi Relationship between nuclear grade of ductal carcinoma in situ and cell origin markers
    Ping Tang
    Department of Pathology and Laboratory Medicine, University of Rochester Medical Center Box 626, 601 Elmwood Ave, Rochester, NY 14642, USA
    Ann Clin Lab Sci 36:16-22. 2006
    ..Further studies are needed to delineate the relationships of cell origin markers in DCIS and invasive carcinoma to the clinical outcome...
  4. ncbi Expression patterns of ER-alpha, PR, HER-2/neu, and EGFR in different cell origin subtypes of high grade and non-high grade ductal carcinoma in situ
    Ping Tang
    Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, 601 Elmwood Ave, Box 626, Rochester, New York 14642 USA
    Ann Clin Lab Sci 36:137-43. 2006
    ....
  5. ncbi Ductal carcinoma in situ: a review of recent advances
    Ping Tang
    Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York 14642, USA
    Curr Opin Obstet Gynecol 19:63-7. 2007
    ..This review summarizes recent findings on ductal carcinoma in situ of the breast and their impact on prognosis and management of the disease...
  6. ncbi Molecular classification of breast carcinomas by immunohistochemical analysis: are we ready?
    Ping Tang
    Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA
    Diagn Mol Pathol 18:125-32. 2009
    ..We also propose a standardized IHC-based molecular classification, in the hope that it will promote more uniform large multicenter studies, and facilitate its clinical application...
  7. ncbi A lower Allred score for progesterone receptor is strongly associated with a higher recurrence score of 21-gene assay in breast cancer
    Ping Tang
    Department of Pathology, University of Rochester of Rochester Medical Center, New York, USA
    Cancer Invest 28:978-82. 2010
    ..926 (mitosis) -2.408 (PR) -1.061 (HER2) + 7.051 (luminal A) + 29.172 (luminal B) predicts RS with an R² of 0.65. In conclusion, PR negativity, luminal B subtype, tubal formation, and mitosis are strongly correlated with a higher RS...
  8. ncbi Reduced expression of tocopherol-associated protein (TAP/Sec14L2) in human breast cancer
    Xi Wang
    Department of Pathology and Laboratory Medicine, University of Rochester Medical School, Rochester, New York, USA
    Cancer Invest 27:971-7. 2009
    ..This downregulation of TAP/Sec14L2 was also present in ductal carcinoma in situ (DCIS) associated with invasive carcinomas. These findings raise the possibility that TAP/Sec14L2 may serve as a tumor suppressor in breast carcinogenesis...
  9. ncbi Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast
    Krisztina Hanley
    Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA
    Hum Pathol 39:386-92. 2008
    ..We purpose that androgen receptor should be routinely measured for breast cancer...
  10. ncbi Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast
    Sharon Steinman
    Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York 14642, USA
    Ann Clin Lab Sci 37:127-34. 2007
    ....
  11. ncbi Different panels of markers should be used to predict mammary Paget's disease associated with in situ or invasive ductal carcinoma of the breast
    Todd Lester
    Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York 14642, USA
    Ann Clin Lab Sci 39:17-24. 2009
    ....
  12. ncbi Dual expression of alpha-tocopherol-associated protein and estrogen receptor in normal/benign human breast luminal cells and the downregulation of alpha-tocopherol-associated protein in estrogen-receptor-positive breast carcinomas
    Sharlin Johnykutty
    Department of Pathology and Laboratory Medicine, University of Rochester Medical School, Rochester, NY 14642, USA
    Mod Pathol 22:770-5. 2009
    ....
  13. ncbi The ubiquitin E3 ligase WWP1 decreases CXCL12-mediated MDA231 breast cancer cell migration and bone metastasis
    Kristina Subik
    Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA
    Bone 50:813-23. 2012
    ....
  14. ncbi Angiosarcoma of the breast: a rare clinicopathological entity
    Tithi Biswas
    Department of Radiation Oncology, University of Rochester Medical Center, 601 Elmwood Ave, Box 647, Rochester, NY 14642, USA
    Am J Clin Oncol 32:582-6. 2009
    ..We examine our institutional experience with angiosarcomas of the breast that were diagnosed and treated between 1996 and 2007...
  15. ncbi Tissue array construction: pitfalls, problems, and progress
    Andrew M Quinn
    Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York 14642, USA
    Appl Immunohistochem Mol Morphol 16:287-90. 2008
    ..Core transfer rates are highest when donor blocks are stored at 4 degrees C before punching and when 0.6-mm diameter cores are taken from donor blocks...
  16. ncbi Some DCIS is different molecularly from DCIS with co-existing IDC
    Sharon Steinman
    Breast J 14:122-3. 2008
  17. ncbi Incidental finding of mammary carcinoma in lumpectomy specimens
    Ping Tang
    Departments of Pathology, North Shore University Hospital, Manhasset, New York 11030, USA
    Ann Clin Lab Sci 33:23-31. 2003
    ..The significance of these microscopic findings for therapeutic strategy and prognosis should be determined by long-term follow-up...